ROGER FELDMAN: Open Payments
NPI 1457420960 · ELMONT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 59 payments from 14 companies in 2025. Trend: 2023 $733 · 2024 $798 · 2025 $1,270
Food & beverage: $1,158Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $215 |
| ABBVIE INC. | 10 | $200 |
| E.R. Squibb & Sons, L.L.C. | 11 | $171 |
| Axsome Therapeutics, Inc. | 6 | $150 |
| Alkermes, Inc. | 6 | $147 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Vanda Pharmaceuticals Inc. | 2 | $64 |
| Lundbeck LLC | 3 | $64 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
| Corium, LLC | 3 | $33 |
Products named: VRAYLAR, Auvelity, COBENFY, ARISTADA, REXULTI, UZEDY, FANAPT, INVEGA SUSTENNA.
Industry payments across NY — which companies pay providers there.
